Role of a Pediatric Cardiologist in the COVID-19 Pandemic.

Published on Jan 1, 2021in Pediatric Cardiology1.564
· DOI :10.1007/S00246-020-02476-Y
Talha Niaz8
Estimated H-index: 8
(Mayo Clinic),
Kyle D. Hope3
Estimated H-index: 3
(BCM: Baylor College of Medicine)
+ 9 AuthorsDevyani Chowdhury12
Estimated H-index: 12
Sources
Abstract
Coronavirus disease 2019 (COVID-19) has affected patients across all age groups, with a wide range of illness severity from asymptomatic carriers to severe multi-organ dysfunction and death. Although early reports have shown that younger age groups experience less severe disease than older adults, our understanding of this phenomenon is in continuous evolution. Recently, a severe multisystem inflammatory syndrome in children (MIS-C), with active or recent COVID-19 infection, has been increasingly reported. Children with MIS-C may demonstrate signs and symptoms of Kawasaki disease, but also have some distinct differences. These children have more frequent and severe gastrointestinal symptoms and are more likely to present with a shock-like presentation. Moreover, they often present with cardiovascular involvement including myocardial dysfunction, valvulitis, and coronary artery dilation or aneurysms. Here, we present a review of the literature and summary of our current understanding of cardiovascular involvement in children with COVID-19 or MIS-C and identifying the role of a pediatric cardiologist in caring for these patients.
References83
Newest
#1Alfredo Tagarro (UEM: European University of Madrid)H-Index: 11
#2Cristina EpalzaH-Index: 5
Last. Cristina Calvo (Hospital Universitario La Paz)H-Index: 25
view all 7 authors...
This case series describes the testing for and treatment of children with coronavirus disease 2019 (COVID-19) in Madrid, Spain.
192 CitationsSource
#1Rawn Salenger (UMB: University of Maryland, Baltimore)H-Index: 6
#2Eric Etchill (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 5
Last. James S. Gammie (UMB: University of Maryland, Baltimore)H-Index: 57
view all 10 authors...
ABSTRACT Background The COVID-19 pandemic has dramatically reduced adult cardiac surgery case volumes as institutions and surgeons curtail non-urgent operations. There will be a progressive increase in deferred cases during the pandemic that will require completion within a limited time frame once restrictions ease. We investigated the impact of various levels of increased post-pandemic hospital operating capacity on the time to clear the backlog of deferred cases. Methods We collected data from...
22 CitationsSource
#1Graham Peigh (NU: Northwestern University)H-Index: 5
#2Marysa V. Leya (NU: Northwestern University)H-Index: 4
Last. James D. Flaherty (NU: Northwestern University)H-Index: 22
view all 6 authors...
Background Novel coronavirus-19 disease (COVID-19) is associated with significant cardiovascular morbidity and mortality. To date, there have not been reports of sinus node dysfunction (SND) associated with COVID-19. This case series describes clinical characteristics, potential mechanisms, and short-term outcomes of COVID-19 patients who experience de novo SND. Case summary We present two cases of new-onset SND in patients recently diagnosed with COVID-19. Patient 1 is a 70-year-old female with...
17 CitationsSource
#1Cheng I. Wu (UvA: University of Amsterdam)H-Index: 1
#2Pieter G. Postema (UvA: University of Amsterdam)H-Index: 23
Last. Arthur A.M. Wilde (UvA: University of Amsterdam)H-Index: 138
view all 11 authors...
Ever since the first case was reported at the end of 2019, the SARS-COV-2 virus and associated lung disease COVID-19 has spread throughout the world and has become a pandemic. In particular, the high transmission rate of the virus has made it a threat to public health globally. Currently, there is no proven effective therapy against the virus, and the impact on other diseases is also uncertain, especially inherited arrhythmia syndrome. Arrhythmogenic effect of COVID-19 can be expected, potential...
83 CitationsSource
#1Nicholas J Mercuro (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 5
#2Christina F Yen (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 5
Last. Howard S. Gold (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 37
view all 7 authors...
Importance Administration of hydroxychloroquine with or without azithromycin for the treatment of coronavirus disease 2019 (COVID-19)–associated pneumonia carries increased risk of corrected QT (QTc) prolongation and cardiac arrhythmias. Objective To characterize the risk and degree of QT prolongation in patients with COVID-19 in association with their use of hydroxychloroquine with or without concomitant azithromycin. Design, Setting, and Participants This was a cohort study performed at an aca...
303 CitationsSource
#1Zahra Belhadjer (University of Paris)H-Index: 3
#2Mathilde MeotH-Index: 4
Last. Damien Bonnet (University of Paris)H-Index: 88
view all 29 authors...
Background: Cardiac injury and myocarditis have been described in adults with COVID-19. SARS-CoV-2 infection in children is typically minimally symptomatic. We report a series of febrile pediatric ...
351 CitationsSource
#1Andrea Giacomelli (University of Milan)H-Index: 14
#2Laura Pezzati (University of Milan)H-Index: 3
Last. Massimo Galli (University of Milan)H-Index: 72
view all 12 authors...
563 CitationsSource
#1Elizabeth Whittaker (Imperial College London)H-Index: 19
#2Alasdair Bamford (GOSH: Great Ormond Street Hospital)H-Index: 10
Last. Perform ConsortiaH-Index: 1
view all 22 authors...
Importance In communities with high rates of coronavirus disease 2019, reports have emerged of children with an unusual syndrome of fever and inflammation. Objectives To describe the clinical and laboratory characteristics of hospitalized children who met criteria for the pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PIMS-TS) and compare these characteristics with other pediatric inflammatory disorders. Design...
476 CitationsSource
#1Eva W. Cheung (Columbia University)H-Index: 8
#2Philip Zachariah (Columbia University)H-Index: 13
Last. Joshua D. Milner (Columbia University)H-Index: 51
view all 7 authors...
This case series describes clinical characteristics, treatment, and outcomes of 17 previously healthy SARS-CoV-2-infected children and adolescents with an inflammatory phenotype overlapping with but distinct from Kawasaki disease and toxic shock syndrome admitted to a New York City hospital in late April and early May 2020.
206 CitationsSource
#1Pietro Enea Lazzerini (UNISI: University of Siena)H-Index: 29
#2Mohamed Boutjdir (NYU: New York University)H-Index: 37
Last. Pier Leopoldo Capecchi (UNISI: University of Siena)H-Index: 33
view all 3 authors...
92 CitationsSource
Cited By2
Newest
#1Tiphanie P. Vogel (BCM: Baylor College of Medicine)H-Index: 17
#2Karina A. Top (Dal: Dalhousie University)H-Index: 12
Last. Flor M. Munoz (BCM: Baylor College of Medicine)H-Index: 38
view all 14 authors...
Abstract This is a Brighton Collaboration Case Definition of the term “Multisystem Inflammatory Syndrome in Children and Adults (MIS-C/A)” to be utilized in the evaluation of adverse events following immunization. The case definition was developed by topic experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2. The format of the Brighton Collaboration was followed, including an exhaustive review of the litera...
3 CitationsSource
#1Bibhuti B. Das (BCM: Baylor College of Medicine)H-Index: 1
The interplay between coronavirus disease 2019 (COVID-19) and pulmonary hypertension (PH) in children is unknown. Adults with PH are at potential risk for severe complications and high mortality due to associated comorbidities. It is difficult to extrapolate the outcomes of COVID-19 in adults to pediatric PH patients. Overall, a small number of COVID-19 cases is reported in patients with preexisting PH. Several factors may be responsible for the low incidence of COVID-19 in children with PH. Pul...
1 CitationsSource